Breakthrough combo trial aims to extend lives of kidney cancer patients
NCT ID NCT05899049
Summary
This study is testing whether adding one or two new drugs to the standard treatment works better for advanced kidney cancer. It involves about 249 Chinese patients who haven't had previous treatment for their advanced cancer. Researchers will compare how long patients live without their cancer getting worse and their overall survival between the different drug combinations.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, RENAL CELL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Cancer hospital-Renal carcinoma and melanoma ( Site 6000)
Beijing, Beijing Municipality, 100142, China
-
Chongqing University Cancer Hospital ( Site 6009)
Chongqing, Chongqing Municipality, 400030, China
-
Guangzhou First People's Hospital ( Site 6007)
Guangzhou, Guangdong, 510180, China
-
Henan Cancer Hospital-Urology ( Site 6006)
Zhengzhou, Henan, 450008, China
-
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( S
Nanjing, Jiangsu, 210000, China
-
Ningbo First Hospital-Urology ( Site 6028)
Ningbo, Zhejiang, 315010, China
-
SUN YAT-SEN UNIVERSITY CANCER CENTRE ( Site 6003)
Guangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital of Guangzhou Medical University-Urology ( Site 6036)
Guangzhou, Guangdong, 510120, China
-
The First Affiliated Hospital of Nanchang University ( Site 6019)
Nanchang, Jiangxi, 330006, China
-
The First Affiliated Hospital of Wenzhou Medical University-Urology Surgery ( Site 6021)
Wenzhou, Zhejiang, 325000, China
-
The First Affiliated Hospital of Xi'an Jiaotong University ( Site 6014)
Xi'an, Shaanxi, 710061, China
-
The First Affiliated Hospital, Zhejiang University ( Site 6024)
Hangzhou, Zhejiang, 310003, China
-
The First Hospital of Jiaxing ( Site 6033)
Jiaxing, Zhejiang, 314001, China
-
The Second Affiliated Hospital of Soochow University-Urology ( Site 6025)
Suzhou, Jiangsu, 215004, China
-
The Second Hospital of Tianjin Medical University ( Site 6032)
Tianjin, Tianjin Municipality, 300211, China
-
West China Hospital Sichuan University-Urology Surgery ( Site 6016)
Chengdu, Sichuan, 610041, China
-
Wuhan Union Hospital ( Site 6002)
Wuhan, Hubei, 430022, China
Conditions
Explore the condition pages connected to this study.